Quarry LP’s Vaxcyte PCVX Stock Holding History

Quarry LP’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$584K	Buy	10,043 +3,043	+43%	+$165K	0.05%	133
2026 Q1	$407K	Buy	7,000 +2,000	+40%	+$109K	0.07%	189
2025 Q4	$231K	Buy	+5,000	New	+$224K	0.04%	254

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Quarry LP's PCVX Position: Q2 2026 in Review

Quarry LP increased its Vaxcyte (PCVX) stake by 43% in Q2 2026, buying an estimated $165K and bringing the position to 10,043 shares worth $584K. The position accounts for 0.05% of the portfolio, ranked #133.

Quarry LP first reported a position in PCVX in Q4 2025 and has held it in 3 quarters since. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Quarry LP held 10,043 shares of Vaxcyte worth $584K as of Q2 2026.
Quarry LP bought 3,043 Vaxcyte shares in Q2 2026, an estimated $165K.
Vaxcyte made up 0.05% of Quarry LP's portfolio in Q2 2026, its #133 holding.
Quarry LP first reported a position in Vaxcyte in Q4 2025 and has held it in 3 quarters since.
332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.